• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

设计并合成新型 3-(苯并[d]异噁唑-3-基)-1-取代吡咯烷-2,5-二酮衍生物作为抗惊厥药物。

Design and synthesis of new of 3-(benzo[d]isoxazol-3-yl)-1-substituted pyrrolidine-2, 5-dione derivatives as anticonvulsants.

机构信息

Department of Pharmaceutical Chemistry, Faculty of Pharmacy Jamia Hamdard (Hamdard University), New Delhi 110062, India.

Department of Pharmaceutical Chemistry, Faculty of Pharmacy Jamia Hamdard (Hamdard University), New Delhi 110062, India.

出版信息

Eur J Med Chem. 2014 Sep 12;84:42-50. doi: 10.1016/j.ejmech.2014.07.016. Epub 2014 Jul 8.

DOI:10.1016/j.ejmech.2014.07.016
PMID:25014748
Abstract

A series of 3-(benzo[d]isoxazol-3-yl)-N-substituted pyrrolidine-2, 5-dione (7a-7d, 8a-8d, 9a-9c) have been prepared and evaluated for their anticonvulsant activities. Preliminary anticonvulsant activity was performed using maximal electroshock (MES) and subcutaneous pentylenetetrazole (scPTZ) tests after intraperitoneal (ip) injection into mice, which are the most widely employed models for early identification of anticonvulsant candidate. The acute neurological toxicity (NT) was determined applying rotorod test. The quantitative evaluation after oral administration in rats showed that the most active was 3-(benzo[d]isoxazol-3-yl)-1-(4-fluorophenyl) pyrrolidine-2, 5-dione (8a) with ED50 values of 14.90 mg/kg. Similarly the most potent in scPTZ was 3-(benzo[d]isoxazol-3-yl)-1-cyclohexylpyrrolidine-2, 5-dione (7d) with ED50 values of 42.30 mg/kg. These molecules were more potent and less neurotoxic than phenytoin and ethosuximide which were used as reference antiepileptic drugs.

摘要

已经合成了一系列 3-(苯并[d]异噁唑-3-基)-N-取代的吡咯烷-2,5-二酮(7a-7d、8a-8d、9a-9c),并评估了它们的抗惊厥活性。初步的抗惊厥活性是通过腹腔内(ip)注射后在小鼠中进行最大电休克(MES)和皮下戊四氮(scPTZ)测试来评估的,这是早期鉴定抗惊厥候选药物最广泛使用的模型。急性神经毒性(NT)通过转棒测试来确定。在大鼠中进行的口服定量评估表明,最活跃的是 3-(苯并[d]异噁唑-3-基)-1-(4-氟苯基)吡咯烷-2,5-二酮(8a),其 ED50 值为 14.90 mg/kg。同样,在 scPTZ 中最有效的是 3-(苯并[d]异噁唑-3-基)-1-环己基吡咯烷-2,5-二酮(7d),其 ED50 值为 42.30 mg/kg。这些分子比苯妥英和乙琥胺更有效且神经毒性更小,苯妥英和乙琥胺被用作参考抗癫痫药物。

相似文献

1
Design and synthesis of new of 3-(benzo[d]isoxazol-3-yl)-1-substituted pyrrolidine-2, 5-dione derivatives as anticonvulsants.设计并合成新型 3-(苯并[d]异噁唑-3-基)-1-取代吡咯烷-2,5-二酮衍生物作为抗惊厥药物。
Eur J Med Chem. 2014 Sep 12;84:42-50. doi: 10.1016/j.ejmech.2014.07.016. Epub 2014 Jul 8.
2
Synthesis and anticonvulsant activity of new 1-[2-oxo-2-(4-phenylpiperazin-1-yl)ethyl]pyrrolidine-2,5-diones.新型 1-[2-氧代-2-(4-苯哌嗪基)-乙基]-吡咯烷-2,5-二酮的合成及抗惊厥活性。
Bioorg Med Chem Lett. 2011 Oct 1;21(19):5800-3. doi: 10.1016/j.bmcl.2011.07.118. Epub 2011 Aug 6.
3
Synthesis and anticonvulsant activity of new N-Mannich bases derived from 3-(2-fluorophenyl)- and 3-(2-bromophenyl)-pyrrolidine-2,5-diones. Part II.新型 N-曼尼希碱的合成及抗惊厥活性研究,其母体为 3-(2-氟苯基)-和 3-(2-溴苯基)-吡咯烷-2,5-二酮。第二部分。
Bioorg Med Chem. 2012 Aug 1;20(15):4872-80. doi: 10.1016/j.bmc.2012.05.032. Epub 2012 May 23.
4
Synthesis, physicochemical, and anticonvulsant properties of new N-Mannich bases derived from pyrrolidine-2,5-dione and its 3-methyl analog.源自吡咯烷-2,5-二酮及其3-甲基类似物的新型N-曼尼希碱的合成、物理化学性质及抗惊厥特性
Arch Pharm (Weinheim). 2014 Oct;347(10):768-76. doi: 10.1002/ardp.201400152. Epub 2014 Aug 19.
5
Design and synthesis of (5-amino-1, 2, 4-triazin-6-yl)(2-(benzo[d] isoxazol-3-yl) pyrrolidin-1-yl)methanone derivatives as sodium channel blocker and anticonvulsant agents.设计和合成(5-氨基-1,2,4-三嗪-6-基)(2-(苯并[d]异噁唑-3-基)吡咯烷-1-基)甲酮衍生物作为钠离子通道阻断剂和抗惊厥药物。
J Enzyme Inhib Med Chem. 2014 Aug;29(4):505-16. doi: 10.3109/14756366.2013.815177. Epub 2013 Aug 5.
6
Synthesis and anticonvulsant properties of new mannich bases derived from 3,3-disubstituted pyrrolidine-2,5-diones. Part IV.3,3-二取代吡咯烷-2,5-二酮衍生的新型曼尼希碱的合成及抗惊厥活性。第四部分。
Arch Pharm (Weinheim). 2012 Sep;345(9):713-22. doi: 10.1002/ardp.201200092. Epub 2012 Jun 6.
7
Synthesis and anticonvulsant activity of new N-[(4-arylpiperazin-1-yl)-alkyl] derivatives of 3-phenyl-pyrrolidine-2,5-dione.新型3-苯基-吡咯烷-2,5-二酮的N-[(4-芳基哌嗪-1-基)-烷基]衍生物的合成与抗惊厥活性
Eur J Med Chem. 2009 May;44(5):2224-33. doi: 10.1016/j.ejmech.2008.05.020. Epub 2008 Jul 7.
8
Design, synthesis and biological evaluation of new hybrid anticonvulsants derived from N-benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide and 2-(2,5-dioxopyrrolidin-1-yl)butanamide derivatives.源自N-苄基-2-(2,5-二氧代吡咯烷-1-基)丙酰胺和2-(2,5-二氧代吡咯烷-1-基)丁酰胺衍生物的新型杂合抗惊厥药的设计、合成及生物学评价
Bioorg Med Chem. 2015 May 15;23(10):2548-61. doi: 10.1016/j.bmc.2015.03.038. Epub 2015 Mar 21.
9
Synthesis, physicochemical and anticonvulsant properties of new N-[(4-arylpiperazin-1-yl)alkyl]-3-phenyl- and 3-(3-methyl-phenyl)-pyrrolidine-2,5-diones.新型N-[(4-芳基哌嗪-1-基)烷基]-3-苯基-和3-(3-甲基苯基)-吡咯烷-2,5-二酮的合成、理化性质及抗惊厥特性
Acta Pol Pharm. 2009 Nov-Dec;66(6):639-47.
10
Synthesis and anticonvulsant properties of new N-Mannich bases derived from 3,3-diphenyl- and 3-ethyl-3-methyl-pyrrolidine-2,5-diones. Part III.合成与新的 N-曼尼希碱的抗惊厥性质源自 3,3-二苯基和 3-乙基-3-甲基-吡咯烷-2,5-二酮。第三部分。
Arch Pharm (Weinheim). 2013 Jan;346(1):71-82. doi: 10.1002/ardp.201200265. Epub 2012 Nov 25.

引用本文的文献

1
The synthetic and therapeutic expedition of isoxazole and its analogs.异恶唑及其类似物的合成与治疗研究
Med Chem Res. 2018;27(5):1309-1344. doi: 10.1007/s00044-018-2152-6. Epub 2018 Feb 27.
2
Benzisoxazole: a privileged scaffold for medicinal chemistry.苯并异恶唑:药物化学中的优势骨架。
Medchemcomm. 2017 Oct 31;8(11):2023-2039. doi: 10.1039/c7md00449d. eCollection 2017 Nov 1.
3
Design and synthesis of chroman derivatives with dual anti-breast cancer and antiepileptic activities.具有双重抗乳腺癌和抗癫痫活性的色满衍生物的设计与合成。
Drug Des Devel Ther. 2016 Sep 2;10:2779-88. doi: 10.2147/DDDT.S111266. eCollection 2016.
4
Current Research on Antiepileptic Compounds.抗癫痫化合物的当前研究
Molecules. 2015 Nov 20;20(11):20741-76. doi: 10.3390/molecules201119714.